Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.
Tutunchi H, Ostadrahimi A, Saghafi-Asl M, Hosseinzadeh-Attar MJ, Shakeri A, Asghari-Jafarabadi M, Roshanravan N, Farrin N, Naemi M, Hasankhani M. Tutunchi H, et al. Among authors: roshanravan n. Pharmacol Res. 2020 Jun;156:104770. doi: 10.1016/j.phrs.2020.104770. Epub 2020 Mar 23. Pharmacol Res. 2020. PMID: 32217148 Clinical Trial.
Effect of Butyrate and Inulin Supplementation on Glycemic Status, Lipid Profile and Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Trial.
Roshanravan N, Mahdavi R, Alizadeh E, Jafarabadi MA, Hedayati M, Ghavami A, Alipour S, Alamdari NM, Barati M, Ostadrahimi A. Roshanravan N, et al. Horm Metab Res. 2017 Nov;49(11):886-891. doi: 10.1055/s-0043-119089. Epub 2017 Sep 29. Horm Metab Res. 2017. PMID: 28962046 Clinical Trial.
The effects of sodium butyrate and inulin supplementation on angiotensin signaling pathway via promotion of Akkermansia muciniphila abundance in type 2 diabetes; A randomized, double-blind, placebo-controlled trial.
Roshanravan N, Mahdavi R, Alizadeh E, Ghavami A, Rahbar Saadat Y, Mesri Alamdari N, Alipour S, Dastouri MR, Ostadrahimi A. Roshanravan N, et al. J Cardiovasc Thorac Res. 2017;9(4):183-190. doi: 10.15171/jcvtr.2017.32. Epub 2017 Nov 25. J Cardiovasc Thorac Res. 2017. PMID: 29391930 Free PMC article.
Assessing the Effect of High Performance Inulin Supplementation via KLF5 mRNA Expression in Adults with Type 2 Diabetes: A Randomized Placebo Controlled Clinical Trail.
Ghavami A, Roshanravan N, Alipour S, Barati M, Mansoori B, Ghalichi F, Nattagh-Eshtivan E, Ostadrahimi A. Ghavami A, et al. Among authors: roshanravan n. Adv Pharm Bull. 2018 Mar;8(1):39-47. doi: 10.15171/apb.2018.005. Epub 2018 Mar 18. Adv Pharm Bull. 2018. PMID: 29670837 Free PMC article.
Effects of oral butyrate and inulin supplementation on inflammation-induced pyroptosis pathway in type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
Roshanravan N, Alamdari NM, Jafarabadi MA, Mohammadi A, Shabestari BR, Nasirzadeh N, Asghari S, Mansoori B, Akbarzadeh M, Ghavami A, Ghaffari S, Ostadrahimi A. Roshanravan N, et al. Cytokine. 2020 Jul;131:155101. doi: 10.1016/j.cyto.2020.155101. Epub 2020 Apr 18. Cytokine. 2020. PMID: 32315958 Clinical Trial.
Effects of saffron supplementation on glycemia and inflammation in patients with type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical trial study.
Mobasseri M, Ostadrahimi A, Tajaddini A, Asghari S, Barati M, Akbarzadeh M, Nikpayam O, Houshyar J, Roshanravan N, Alamdari NM. Mobasseri M, et al. Among authors: roshanravan n. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):527-534. doi: 10.1016/j.dsx.2020.04.031. Epub 2020 Apr 29. Diabetes Metab Syndr. 2020. PMID: 32408117 Clinical Trial.
70 results